Skip to content

Clinical trials

Phase 1 Insulin Resistance trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Insulin Resistance Phase: Phase 1 Clear all

169 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20033
20043
20056
20068
20075
20087
200913
20107
20119
20129
20137
20148
20156
20165
20178
20182
20197
20209
20216
20226
20235
20247
20258
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed118
Recruiting14
Unknown status10
Withdrawn9
Active, not recruiting7
Terminated7
Not yet recruiting3
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Columbia University11
Vanderbilt University Medical Center7
Stanford University6
University of Missouri-Columbia5
Halozyme Therapeutics4
Mayo Clinic4
Pennington Biomedical Research Center4
Eli Lilly and Company3
Gan and Lee Pharmaceuticals, USA3
University of Copenhagen3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Insulin Resistance169
Obesity35
Diabetes Mellitus, Type 232
Diabetes Mellitus27
Diabetes Mellitus, Type 116
Hyperinsulinism12
Prediabetic State10
Inflammation8
Non-alcoholic Fatty Liver Disease7
Overweight7

Trials

Showing 1 to 25 of 169. Each trial links to its page on Pharma Observatory.

69 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.